IL99306A - תולדות אלקילאמידים הטרוציקליים, אגוניסטי שם סרוטונין a1th5 תהליך להכנתם ותכשירים תרופתיים המכילים אותן - Google Patents
תולדות אלקילאמידים הטרוציקליים, אגוניסטי שם סרוטונין a1th5 תהליך להכנתם ותכשירים תרופתיים המכילים אותןInfo
- Publication number
- IL99306A IL99306A IL9930691A IL9930691A IL99306A IL 99306 A IL99306 A IL 99306A IL 9930691 A IL9930691 A IL 9930691A IL 9930691 A IL9930691 A IL 9930691A IL 99306 A IL99306 A IL 99306A
- Authority
- IL
- Israel
- Prior art keywords
- compound according
- phenyl
- represented
- ppm
- nmr
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57471090A | 1990-08-29 | 1990-08-29 | |
US07/735,700 US5189179A (en) | 1990-08-29 | 1991-07-30 | Serotonin 5ht1a agonists |
Publications (2)
Publication Number | Publication Date |
---|---|
IL99306A0 IL99306A0 (en) | 1992-07-15 |
IL99306A true IL99306A (he) | 1995-03-30 |
Family
ID=27076473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9930691A IL99306A (he) | 1990-08-29 | 1991-08-26 | תולדות אלקילאמידים הטרוציקליים, אגוניסטי שם סרוטונין a1th5 תהליך להכנתם ותכשירים תרופתיים המכילים אותן |
Country Status (21)
Country | Link |
---|---|
US (3) | US5189179A (he) |
EP (1) | EP0478954B1 (he) |
JP (1) | JPH04270264A (he) |
KR (1) | KR920004345A (he) |
CN (1) | CN1030766C (he) |
AT (1) | ATE197040T1 (he) |
AU (1) | AU641535B2 (he) |
CA (1) | CA2049803A1 (he) |
DE (1) | DE69132450T2 (he) |
DK (1) | DK0478954T3 (he) |
ES (1) | ES2153346T3 (he) |
FI (1) | FI914065A (he) |
GR (1) | GR3035062T3 (he) |
HU (1) | HU208955B (he) |
IE (1) | IE913036A1 (he) |
IL (1) | IL99306A (he) |
NO (1) | NO175430C (he) |
NZ (1) | NZ239521A (he) |
PH (1) | PH30242A (he) |
PT (1) | PT98800B (he) |
TW (1) | TW200457B (he) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5189179A (en) * | 1990-08-29 | 1993-02-23 | Merrell Dow Pharmaceuticals Inc. | Serotonin 5ht1a agonists |
US5892112A (en) * | 1990-11-21 | 1999-04-06 | Glycomed Incorporated | Process for preparing synthetic matrix metalloprotease inhibitors |
USRE38506E1 (en) | 1991-10-04 | 2004-04-20 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
US6406859B1 (en) | 1992-01-08 | 2002-06-18 | Synaptic Pharmaceutical Corporation | DNA encoding a 5-HT 1F receptor and uses thereof |
GB9211277D0 (en) | 1992-05-28 | 1992-07-15 | Glaxo Group Inc | Pharmaceutical compositions |
GB9304632D0 (en) * | 1993-03-06 | 1993-04-21 | Wyeth John & Brother Ltd | Amide derivatives |
FR2707294B1 (fr) * | 1993-07-06 | 1995-09-29 | Pf Medicament | Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine. |
US5478572A (en) * | 1994-09-06 | 1995-12-26 | Bristol-Myers Squibb Co. | Gepirone dosage form |
AU706839B2 (en) | 1996-03-29 | 1999-06-24 | Pfizer Inc. | Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ANT)agonists of 5-HT1A- and/or 5-HT1D receptors |
US8022095B2 (en) * | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US6586458B1 (en) | 1996-08-16 | 2003-07-01 | Pozen Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US5872145A (en) * | 1996-08-16 | 1999-02-16 | Pozen, Inc. | Formulation of 5-HT agonist and NSAID for treatment of migraine |
US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
US6121307A (en) * | 1998-04-08 | 2000-09-19 | American Home Products Corp. | N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
US6150533A (en) * | 1998-04-08 | 2000-11-21 | American Home Products Corp. | N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
CN1304409A (zh) * | 1998-04-08 | 2001-07-18 | 美国家用产品公司 | 用于治疗抑郁症的吲哚-3-基-环己胺衍生物(5-ht1受体拮抗剂) |
AU3386199A (en) * | 1998-04-08 | 1999-10-25 | American Home Products Corporation | N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents) |
ATE227718T1 (de) * | 1998-04-08 | 2002-11-15 | Wyeth Corp | N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen |
US7588029B2 (en) * | 2000-03-21 | 2009-09-15 | Fisher & Paykel Healthcare Limited | Humidified gases delivery apparatus |
AU2002325712C1 (en) | 2001-08-30 | 2008-07-31 | Stem Cell Therapeutics Inc. | Differentiation of neural stem cells and therapeutic use theeof |
JP4906231B2 (ja) * | 2001-09-14 | 2012-03-28 | ステム セル セラピューティクス インコーポレイテッド | プロラクチン誘導性の神経幹細胞数の増加ならびにその治療用途 |
US20030054551A1 (en) * | 2001-09-18 | 2003-03-20 | Stem Cell Therapeutics Inc. | Effect of growth hormone and IGF-1 on neural stem cells |
CA2492442A1 (en) * | 2002-07-31 | 2004-02-05 | Stem Cell Therapeutics Inc. | Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (pacap) |
ES2380827T3 (es) * | 2002-12-26 | 2012-05-18 | Pozen, Inc. | Formas de dosificación con múltiples capas que contienen naproxeno y triptanes |
BRPI0410807A (pt) * | 2003-06-06 | 2006-06-27 | Glaxo Group Ltd | composição farmacêutica, e, método pata tratar um mamìfero sofrendo de ou susceptìvel a condições associadas com dor cefálica |
WO2005018541A2 (en) * | 2003-07-11 | 2005-03-03 | Pharmacia Corporation | Cox-2 inhibitor and serotonin modulator for treating cns damage |
US20070111932A1 (en) * | 2003-07-31 | 2007-05-17 | Stem Cell Therapeutics Inc. | Method of enhancing and/or inducing neuronal migration using erythropoietin |
JP2007503396A (ja) * | 2003-08-22 | 2007-02-22 | ファルマシア コーポレイション | 新形成の治療のためのシクロオキシゲナーゼ−2選択的阻害剤及びセロトニン−調節剤の組成物 |
CN1325673C (zh) * | 2003-12-30 | 2007-07-11 | 上海交通大学 | 利用废旧紫铜生产无氧铜的装置 |
AU2005211847B2 (en) * | 2004-02-13 | 2011-02-24 | Stem Cell Therapeutics Corp. | Use of luteinizing hormone (LH) and chorionic gonadotropin (hCG) for proliferation of neural stem cells and neurogenesis |
MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
US8283478B2 (en) | 2005-05-20 | 2012-10-09 | Janssen Pharmaceutica Nv | Process for preparation of sulfamide derivatives |
JP2009509943A (ja) | 2005-09-27 | 2009-03-12 | ステム セル セラピューティクス コーポレイション | プロラクチンにより制御される乏突起膠細胞前駆体細胞の増殖 |
US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
US8492431B2 (en) | 2005-12-19 | 2013-07-23 | Janssen Pharmaceutica, N.V. | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
US20070191474A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine |
WO2007106987A1 (en) * | 2006-03-17 | 2007-09-27 | Stem Cell Therapeutics Corp. | Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents |
JP2009537635A (ja) | 2006-05-19 | 2009-10-29 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 癲癇の処置のための共同−療法 |
US8809385B2 (en) | 2008-06-23 | 2014-08-19 | Janssen Pharmaceutica Nv | Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
CN111116451A (zh) * | 2020-01-16 | 2020-05-08 | 宁波大学 | 一种多取代色胺基苯甲酰胺类化合物及其制备方法和用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2725386A (en) * | 1953-02-13 | 1955-11-29 | Fond Emanuele Paterno | 2-(1, 4-benzodioxan) methyl derivatives of amino-lower fatty acid amides and preparation thereof |
FR2463765A1 (fr) * | 1979-08-17 | 1981-02-27 | Clin Midy | Nouveaux derives de l'indole actifs sur le systeme cardiovasculaire |
US4684739A (en) * | 1980-12-15 | 1987-08-04 | Mitsubishi Chemical Industries Limited | Alkylenedioxybenzene derivatives and acid addition salts thereof |
US4614807A (en) * | 1984-10-04 | 1986-09-30 | Eli Lilly And Company | 6,7-dihalomelatonins |
ATE65084T1 (de) * | 1986-06-26 | 1991-07-15 | Ciba Geigy Ag | Hydrierte 1-benzooxacycloalkylpyridincarbons|ureverbindungen. |
DE3642497A1 (de) * | 1986-12-12 | 1988-06-23 | Hoechst Ag | Substituierte aminopropionsaeureamide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte |
US4956382A (en) * | 1987-02-07 | 1990-09-11 | Pfizer Inc. | Sulfonamide anti-arrhythmic agents |
US5189179A (en) * | 1990-08-29 | 1993-02-23 | Merrell Dow Pharmaceuticals Inc. | Serotonin 5ht1a agonists |
US5120758A (en) * | 1991-02-08 | 1992-06-09 | Ciba-Geigy Corporation | Certain benzodioxole, benzodioxane and benzodioxepin derivatives useful as 5-lipoxygenase inhibitors |
-
1991
- 1991-07-30 US US07/735,700 patent/US5189179A/en not_active Expired - Fee Related
- 1991-08-23 CA CA002049803A patent/CA2049803A1/en not_active Abandoned
- 1991-08-23 AU AU82664/91A patent/AU641535B2/en not_active Ceased
- 1991-08-23 NZ NZ239521A patent/NZ239521A/xx unknown
- 1991-08-26 IL IL9930691A patent/IL99306A/he unknown
- 1991-08-27 KR KR1019910014843A patent/KR920004345A/ko not_active Application Discontinuation
- 1991-08-28 PT PT98800A patent/PT98800B/pt not_active IP Right Cessation
- 1991-08-28 HU HU912810A patent/HU208955B/hu not_active IP Right Cessation
- 1991-08-28 ES ES91114456T patent/ES2153346T3/es not_active Expired - Lifetime
- 1991-08-28 FI FI914065A patent/FI914065A/fi not_active Application Discontinuation
- 1991-08-28 DE DE69132450T patent/DE69132450T2/de not_active Expired - Fee Related
- 1991-08-28 EP EP91114456A patent/EP0478954B1/en not_active Expired - Lifetime
- 1991-08-28 DK DK91114456T patent/DK0478954T3/da active
- 1991-08-28 NO NO913384A patent/NO175430C/no unknown
- 1991-08-28 IE IE303691A patent/IE913036A1/en not_active Application Discontinuation
- 1991-08-28 AT AT91114456T patent/ATE197040T1/de not_active IP Right Cessation
- 1991-08-29 PH PH43017A patent/PH30242A/en unknown
- 1991-08-29 TW TW080106873A patent/TW200457B/zh active
- 1991-08-29 CN CN91108614A patent/CN1030766C/zh not_active Expired - Fee Related
- 1991-08-29 JP JP3242328A patent/JPH04270264A/ja active Pending
-
1992
- 1992-10-16 US US07/962,434 patent/US5387604A/en not_active Expired - Fee Related
-
1994
- 1994-10-07 US US08/319,916 patent/US5559143A/en not_active Expired - Fee Related
-
2000
- 2000-12-13 GR GR20000402750T patent/GR3035062T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ239521A (en) | 1993-07-27 |
KR920004345A (ko) | 1992-03-27 |
DK0478954T3 (da) | 2001-01-08 |
PH30242A (en) | 1997-02-05 |
PT98800A (pt) | 1992-08-31 |
HU208955B (en) | 1994-02-28 |
ES2153346T3 (es) | 2001-03-01 |
CA2049803A1 (en) | 1992-03-01 |
EP0478954A1 (en) | 1992-04-08 |
NO175430B (no) | 1994-07-04 |
IE913036A1 (en) | 1992-03-11 |
GR3035062T3 (en) | 2001-03-30 |
CN1059717A (zh) | 1992-03-25 |
EP0478954B1 (en) | 2000-10-18 |
US5559143A (en) | 1996-09-24 |
HUT59092A (en) | 1992-04-28 |
AU8266491A (en) | 1992-03-05 |
DE69132450D1 (de) | 2000-11-23 |
ATE197040T1 (de) | 2000-11-15 |
DE69132450T2 (de) | 2001-05-03 |
TW200457B (he) | 1993-02-21 |
FI914065A (fi) | 1992-03-01 |
US5189179A (en) | 1993-02-23 |
NO175430C (no) | 1994-10-12 |
PT98800B (pt) | 1999-01-29 |
CN1030766C (zh) | 1996-01-24 |
FI914065A0 (fi) | 1991-08-28 |
NO913384D0 (no) | 1991-08-28 |
NO913384L (no) | 1992-03-02 |
US5387604A (en) | 1995-02-07 |
JPH04270264A (ja) | 1992-09-25 |
IL99306A0 (en) | 1992-07-15 |
AU641535B2 (en) | 1993-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0478954B1 (en) | Serotonin 5HT1A and 5HT1D agonists | |
US5604261A (en) | Arylalkyl (thio)amides | |
JPH0428698B2 (he) | ||
FR2903101A1 (fr) | Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
AU2004255191A1 (en) | Phenylcarboxylate beta-secretase inhibitors for the treatment of Alzheimer's disease | |
PL128296B1 (en) | Process for preparing novel 3-/1-imidazolylalkyl/-indoles | |
PL191876B1 (pl) | Nowe kwasy sulfonyloaminokarboksylowe i sposób ich wytwarzania, środek farmaceutyczny i ich zastosowanie do wytwarzania leku | |
JPS61249960A (ja) | N―インドリルエチル―スルホン酸アミド類、その製法及び用途 | |
BG63940B1 (bg) | Бифенилсулфонамидни инхибитори на металопротеиназата на матрикса | |
EP0406734A2 (en) | 2-(Aminoaryl)indoles and indolines, a process for their preparation and their use as medicaments | |
FR2635104A1 (fr) | Derives d'indolone, leur preparation et leur application en therapeutique | |
FR2630328A1 (fr) | Derive de l'histamine, sa preparation et son application en therapeutique | |
IL203956A (he) | נגזרות אינדול – 2 – און דו–מותמרות בעמדה 3, הכנתן ושימוש שלהן להכנת תרופות | |
KR900004385B1 (ko) | 카복사미드 유도체 및 그의 제조방법 | |
NO311257B1 (no) | Indoler med brostruktur som matriksmetallproteaseinhibitorer, samt farmasöytiske preparater som omfatter dem | |
EP0526478B1 (en) | 3-indolyl thioacetate derivatives | |
NZ524404A (en) | Indole derivatives and their use as medicaments | |
FR2680172A1 (fr) | Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique. | |
JPH0625128A (ja) | 新規なナフタレンアミドおよびナフタレンスルホンアミド化合物 | |
EP0841330B1 (fr) | Nouveaux dérivés aminométhyl hétérocycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
KR20060036091A (ko) | 신규 화합물 | |
EP0782568B1 (fr) | Ethers aromatiques derives d'indoles comme "5ht1-like" ligands | |
BG62349B2 (bg) | N-заместени производни на 3-азабицикло/3.2.0/хептан като невролептици | |
AU2002300093B2 (en) | New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them | |
JP2003523343A (ja) | アミノ酸化合物、ならびにnep、aceおよびece阻害剤としてのその使用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
HC | Change of name of proprietor(s) | ||
HC | Change of name of proprietor(s) |
Owner name: AVENTIS INC. Free format text: FORMER NAME:MERRELL PARMACEUTICALS, INC. |